Future Medicine, part of Future Science Group, UK, has announced the launch of Epigenomics - a new journal addressing the key technological advances that elucidate the inner working of the genome. The editorial direction of the journal is the responsibility of Senior Editors Dr James G. Herman of the John Hopkins Oncology Center, Baltimore, and Dr Jörg Tost of the Centre National de Génotypage, France. They will be supported by a team of three Associate Editors, together with an Advisory Panel of more than thirty international experts.
A bimonthly publication, Epigenomics provides a critical overview of the latest and most significant advances as they unfold and explores how these impact our understanding of human development and disease. The journal publishes reviews, original research, perspectives, commentary and news & views for the interdisciplinary epigenomics community. Epigenomics articles are resented in highly accessible formats.
The journal further complements Future Medicine's post-genomic portfolio, which includes Pharmacogenomics, Biomarkers in Medicine, Regenerative Medicine and Personalized Medicine. All articles submitted to the journal are subject to peer review by three, or more, independent assessors. The launch issue is currently available online at http://www.futuremedicine.com/loi/epi.
Search for more such medical books/journals in K-Store
Discuss this NEWS
